KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Nu Skin Enterprises (NUS) Other financing activities (2016 - 2026)

Nu Skin Enterprises' Other financing activities history spans 10 years, with the latest figure at $649000.0 for Q4 2025.

On a quarterly basis, Other financing activities changed N/A to $649000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a N/A change, with the full-year FY2025 number at $3.6 million, changed N/A from a year prior.
Other financing activities hit $649000.0 in Q4 2025 for Nu Skin Enterprises, down from $1.8 million in the prior quarter.
Over the last five years, Other financing activities for NUS hit a ceiling of $2.7 million in Q2 2025 and a floor of -$1.5 million in Q1 2025.